Diabetes News and Research

Latest Diabetes News and Research

ASM to honor LA BioMed investigator for A. baumannii infection study

Ashraf Ibrahim, Ph.D., principal investigator at LA BioMed who specializes in infectious diseases, was recently honored by the American Society for Microbiology (ASM) and the ICAAC Program Committee in the area of Therapy and Prevention of Microbial Disease.

14 Sep 2011

BVES protein may play a role in colon cancer progression

A protein critical in heart development may also play a part in colon cancer progression. Research led by investigators from Vanderbilt-Ingram Cancer Center and the Vanderbilt Eye Institute suggests that the protein BVES (blood vessel endocardial substance) - which also is key in regulating corneal cells - may be a therapeutic target for halting colon cancer metastasis.

14 Sep 2011

A woman's pregnancy outcome can be an indicator of future health conditions

"A woman's pregnancy outcome can be an indicator of future health conditions," stated George R. Saade, M.D., president of the Society for Maternal-Fetal Medicine and professor of obstetrics and gynecology at The University of Texas Medical Branch in Galveston, Texas.

14 Sep 2011

IDF, Albert Einstein College of Medicine to host Global Diabetes Symposium

While infectious diseases tend to grab media headlines and public attention, non-communicable diseases such as diabetes, cancer, cardiovascular disease, and chronic respiratory diseases together comprise the number one killer in the world and represent a serious social and economic burden to developed and developing countries alike.

14 Sep 2011

Black women with wide waists are equally at risk of early death as whites

Ever since the mid-1970s when Harvard initiated what is now known as "The Nurses Study" we've been told that white women with waists over 40 inches, raised their risk of early death by 40% vs. their slimmer sisters who maintained waists in the 26 to 27 inch measure.

14 Sep 2011

Diabetes epidemic grips the world

Experts are horrified with the rise of numbers of diabetics worldwide. A staggering 366 million people around the world have either Type 1 or 2 diabetes, says the International Diabetes Federation. The disease has taken a deadly toll, causing 4.6 million deaths each year, or one death every seven seconds. The number of sufferers was pegged at 285 million worldwide in 2009. Since then, China reported 92.4 million people with the condition, more than double the federation’s estimate. The diabetes epidemic is also heavy on healthcare spending, to the tune of $465 billion a year to fight the disease.

14 Sep 2011

Pure maple syrup may promote a healthy liver

New research conducted at the University of Tokyo suggests that pure maple syrup may promote a healthy liver.

14 Sep 2011

Survey highlights need for better diabetes treatment guidelines

A survey of federally funded diabetes prevention and control programs in 57 U.S. states and territories has highlighted the need for better diabetes treatment guidelines that are specifically adapted to different populations. Such guidelines do not currently exist.

14 Sep 2011

Lexicon's LX4211 clinical data presented at EASD annual meeting

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced today that the company is presenting clinical data this week at the European Association for the Study of Diabetes (EASD) annual meeting in Lisbon, Portugal.

14 Sep 2011

VIVUS presents positive results from avanafil phase 3 study in diabetics at 47th EASD meeting

VIVUS, Inc. today presented positive results from the avanafil phase 3 study in diabetics. In the REVIVE-Diabetes study (TA-302), male diabetics receiving avanafil had significant improvement in erectile function.

14 Sep 2011

Practical NCD guide for everyone to improve their health

The world's health professions have launched an easy-to-use, practical guide to help individuals and their health professionals reduce the risk of noncommunicable diseases (NCDs) - conditions which currently account for 60% of global deaths.

14 Sep 2011

African-Americans have higher risk of high blood pressure earlier

...

13 Sep 2011

A squirt of insulin up the nose for prevention of Alzheimer’s disease

Researchers have noted in a small pilot study that squirting insulin deep into the nose where it travels to the brain might hold early Alzheimer’s disease at bay. At present there are no effective ways to prevent or delay the progress of Alzheimer’s. More than 5.4 million Americans and 35 million people worldwide have Alzheimer's, the most common form of dementia.

13 Sep 2011

New data from Bayer's investigational oncology compounds to be presented at ECCO-ESMO congress

Bayer HealthCare announced today that the company will present data on several of its investigational compounds at the 2011 European Multidisciplinary Cancer Congress (ECCO-ESMO), September 23-27, 2011, in Stockholm, Sweden.

13 Sep 2011

People with high cholesterol more likely to develop Alzheimer's disease

People with high cholesterol may have a higher risk of developing Alzheimer's disease, according to a study published in the September 13, 2011, issue of Neurology, the medical journal of the American Academy of Neurology.

13 Sep 2011

Cardiotrophin 1 has marked effect on fat and glucose metabolism

Scientists from the Center for Applied Medical Research (CIMA) of the University of Navarra (Spain) have discovered that cardiotrophin 1, a protein synthesized by muscle cells and adipose tissue, has a marked effect on fat and glucose metabolism.

13 Sep 2011

Largest cardiology conference in Latin America

Against a background of high mortality rates from cardiovascular disease (CVD) in Brazil, the European Society of Cardiology (ESC) is to deliver an educational programme at the 66th Annual Congress of the Brazilian Society of Cardiology.

13 Sep 2011

Lantus initiation may help limit weight gain in type 2 diabetes patients

Sanofi announced today data that demonstrates that initiating Lantus® (insulin glargine [rDNA origin] injection) in type 2 diabetes patients leads to better glycemic control and comparable and modest weight gain versus a comparator group consisting of other insulins, oral antidiabetics and dietary changes.

12 Sep 2011

Sanofi's Lyxumia achieves primary efficacy endpoint in study of patients uncontrolled on metformin

Sanofi announced today that Lyxumia (lixisenatide), a once-daily GLP-1 receptor agonist under development for type 2 diabetes, achieved its primary efficacy endpoint of significant HbA1c reduction vs. placebo in patients uncontrolled on metformin.

12 Sep 2011